FibroGen, Inc. (BMV:FGEN)
Mexico
· Delayed Price · Currency is MXN 105.00
0.00 (0.00%)
At close: Jun 20, 2025, 2:00 PM CST
FibroGen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 7 | 29.62 | 46.8 | 140.73 | 235.31 | 176.32 | Upgrade
| |
Revenue Growth (YoY) | -80.57% | -36.71% | -66.74% | -40.19% | 33.46% | -31.28% | Upgrade
|
Cost of Revenue | 62.85 | 111.25 | 295.07 | 299.95 | 449.19 | 260.64 | Upgrade
|
Gross Profit | -55.85 | -81.63 | -248.27 | -159.21 | -213.88 | -84.32 | Upgrade
|
Selling, General & Admin | 40.72 | 49.33 | 86.48 | 141.81 | 134.65 | 107.56 | Upgrade
|
Operating Expenses | 40.72 | 49.33 | 86.48 | 141.81 | 134.65 | 107.56 | Upgrade
|
Operating Income | -96.57 | -130.96 | -334.75 | -301.03 | -348.53 | -191.88 | Upgrade
|
Interest Expense | -8.41 | -8.25 | -8.1 | -1.44 | -1.08 | -2.4 | Upgrade
|
Interest & Investment Income | 5.3 | 5.3 | 7.87 | 7.6 | - | 5.81 | Upgrade
|
Earnings From Equity Investments | - | - | - | 1.57 | 1.01 | -0.2 | Upgrade
|
Other Non Operating Income (Expenses) | -1.82 | - | - | - | -1.08 | - | Upgrade
|
EBT Excluding Unusual Items | -101.51 | -133.91 | -334.98 | -293.29 | -349.68 | -188.67 | Upgrade
|
Merger & Restructuring Charges | -19.58 | -19.45 | -12.61 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -0.27 | -0.01 | - | -0.26 | Upgrade
|
Pretax Income | -121.09 | -153.37 | -323.22 | -293.3 | -289.68 | -188.93 | Upgrade
|
Income Tax Expense | -0.27 | -0.27 | -0.25 | 0.36 | 0.35 | 0.36 | Upgrade
|
Earnings From Continuing Operations | -120.82 | -153.1 | -322.97 | -293.65 | -290.02 | -189.29 | Upgrade
|
Earnings From Discontinued Operations | 110.81 | 105.52 | 38.74 | - | - | - | Upgrade
|
Net Income | -10.01 | -47.58 | -284.23 | -293.65 | -290.02 | -189.29 | Upgrade
|
Net Income to Common | -10.01 | -47.58 | -284.23 | -293.65 | -290.02 | -189.29 | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Change (YoY) | 2.20% | 2.82% | 3.98% | 1.33% | 2.78% | 3.72% | Upgrade
|
EPS (Basic) | -2.49 | -11.89 | -73.03 | -78.45 | -78.51 | -52.67 | Upgrade
|
EPS (Diluted) | -2.49 | -11.89 | -73.03 | -78.45 | -78.51 | -52.67 | Upgrade
|
Free Cash Flow | -76.25 | -138.27 | -317.54 | -149.67 | -87.42 | 77.61 | Upgrade
|
Free Cash Flow Per Share | -18.96 | -34.55 | -81.58 | -39.98 | -23.66 | 21.59 | Upgrade
|
Gross Margin | - | -275.59% | - | -113.13% | -90.89% | -47.82% | Upgrade
|
Operating Margin | -1380.42% | -442.13% | -715.23% | -213.90% | -148.12% | -108.82% | Upgrade
|
Profit Margin | -143.04% | -160.63% | -607.29% | -208.66% | -123.25% | -107.36% | Upgrade
|
Free Cash Flow Margin | -1089.84% | -466.78% | -678.46% | -106.35% | -37.15% | 44.02% | Upgrade
|
EBITDA | -94.38 | -128.27 | -324.82 | -290.42 | -333.72 | -169.83 | Upgrade
|
EBITDA Margin | - | - | - | -206.36% | -141.82% | -96.32% | Upgrade
|
D&A For EBITDA | 2.2 | 2.69 | 9.93 | 10.6 | 14.81 | 22.05 | Upgrade
|
EBIT | -96.57 | -130.96 | -334.75 | -301.03 | -348.53 | -191.88 | Upgrade
|
EBIT Margin | - | - | - | -213.90% | -148.12% | -108.82% | Upgrade
|
Revenue as Reported | 7 | 29.62 | 46.8 | 140.73 | 235.31 | 176.32 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.